A substantial proportion of the genome encodes membrane proteins that are delivered to the endoplasmic reticulum by dedicated targeting pathways 1 . Membrane proteins that fail targeting must be rapidly degraded to avoid aggregation and disruption of cytosolic protein homeostasis 2, 3 . The mechanisms of mislocalized protein (MLP) degradation are unknown. Here we reconstitute MLP degradation in vitro to identify factors involved in this pathway. We find that nascent membrane proteins tethered to ribosomes are not substrates for ubiquitination unless they are released into the cytosol. Their inappropriate release results in capture by the Bag6 complex, a recently identified ribosome-associating chaperone 4 . Bag6complex-mediated capture depends on the presence of unprocessed or non-inserted hydrophobic domains that distinguish MLPs from potential cytosolic proteins. A subset of these Bag6 complex 'clients' are transferred to TRC40 for insertion into the membrane, whereas the remainder are rapidly ubiquitinated. Depletion of the Bag6 complex selectively impairs the efficient ubiquitination of MLPs. Thus, by its presence on ribosomes that are synthesizing nascent membrane proteins, the Bag6 complex links targeting and ubiquitination pathways. We propose that such coupling allows the fast tracking of MLPs for degradation without futile engagement of the cytosolic folding machinery.
Protein targeting and translocation to the endoplasmic reticulum (ER) are not perfectly efficient 5, 6 , thereby necessitating pathways for the degradation of MLPs that have been inappropriately released into the cytosol. For example, mammalian prion protein (PrP), a widely expressed glycosyl phosphatidylinositol (GPI)-anchored cell surface glycoprotein, displays ,5-15% translocation failure in vitro and in vivo 2, 3, [5] [6] [7] [8] [9] [10] . This non-translocated population of PrP is degraded efficiently by a proteasome-dependent pathway, limiting the cytosolic PrP levels at steady state 2, 3, 9, 10 . Prompt degradation is essential because mislocalized PrP can aggregate, make inappropriate interactions, and cause cell death and neurodegeneration 2, [11] [12] [13] [14] . The pathways for efficient disposal of MLPs, however, are not known.
To study this problem, we reconstituted the ubiquitination of mislocalized PrP in vitro. Radiolabelled PrP synthesized in rabbit reticulocyte lysate (RRL) supplemented with ER-derived rough microsomes was predominantly translocated into the ER, processed and glycosylated ( Fig. 1a ). However, various conditions that reduced the extent of translocation-such as omission of rough microsomes, inactivation of signal recognition particle (SRP)-dependent targeting or blocking of translocation through the translocon-all resulted in increased PrP ubiquitination in a lysine-dependent manner ( Fig. 1a and Supplementary Figs 1-3). Other mislocalized secretory and membrane proteins were also similarly ubiquitinated in the cytosol ( Supplementary Fig. 4 ). The ubiquitination of mislocalized PrP closely parallels PrP synthesis ( Fig. 1b ), suggesting that ubiquitination is rapid. Yet, ubiquitination occurred strictly post-translationally, because full-length PrP that was tethered as a nascent peptidyl-transfer RNA to the ribosome was not ubiquitinated until it had been released into the cytosol through the action of puromycin ( Fig. 1c and Supplementary Fig. 5 ). An unrelated membrane protein behaved similarly ( Supplementary Fig. 6 ).
Efficient ubiquitination of PrP was strongly dependent on unprocessed hydrophobic signals at the amino and carboxy termini ( Fig. 1d ). Conversely, green fluorescent protein (GFP) became a substrate for ubiquitination when hydrophobic targeting signals were added ( Supplementary Fig. 4 ). Ubiquitination was therefore not solely a consequence of protein misfolding, because PrP lacking both the N-terminal targeting signal (denoted DSS) and the C-terminal GPI-anchoring signal (DGPI) was misfolded owing to its lack of glycosylation and disulphide bond formation, but was poorly ubiquitinated. This finding suggested the existence of a specialized pathway for hydrophobic-domaincontaining MLPs that works more rapidly than traditional quality control pathways, which engage only after repeated failures at folding 15, 16 .
To identify factors involved in the MLP degradation pathway, we combined biochemical fractionation and functional reconstitution assays. We produced a translation-competent fractionated RRL (Fr-RRL) ( Supplementary Fig. 7 ) that selectively decreased the ubiquitination of non-translocated PrP ( Fig. 2a Supplementary Fig. 7 ). The missing factor in Fr-RRL (other than ubiquitin, which we included in all assays) proved to be the E2 ubiquitin-conjugating enzyme UBCH5 (also known as UBE2D1) ( Fig. 2b and Supplementary Figs 8 and 9 ). Because UBCH5 restored ubiquitination equally well when added during or after PrP translation ( Fig. 2b ), we surmised that at least a certain population of PrP remains in a ubiquitination-competent state. Indeed, PrP and other MLPs that were affinity purified from Fr-RRL under native conditions could be ubiquitinated simply by adding purified E1, UBCH5, ubiquitin and ATP ( Fig. 2c and Supplementary Fig. 10 ).
To identify factors that maintain the ubiquitination competence of MLPs, the Fr-RRL translation products were separated by size in a sucrose gradient, and each fraction was subjected to parallel ubiquitination and chemical crosslinking analyses ( Fig. 2d and Supplementary  Fig. 11 ). The fractions retaining maximum ubiquitination competence for two different substrates correlated well with a ,150-kDa crosslinking partner ( Fig. 2d and Supplementary Fig. 11 ). This interaction was direct ( Supplementary Fig. 12 ) and was strongly dependent on the presence of unprocessed N-and C-terminal signals in PrP ( Fig. 2e and Supplementary Fig. 13 ), correlating with the requirements for ubiquitination ( Fig. 1d ). On the basis of molecular weight, dependence on hydrophobic domains for interaction and migration position in the sucrose gradient, we surmised that the ,150-kDa crosslinked protein might be BAG6 (also called BAT3 and Scythe), a hypothesis that was subsequently verified by immunoprecipitation experiments ( Fig. 2e and Supplementary Figs 13 and 14 ). BAG6 was recently identified as part of a three-protein ribosome-interacting chaperone complex (composed of BAG6, TRC35 and UBL4A) 4 that is involved in tailanchored membrane-protein insertion into the ER 4, 17 . A combination of crosslinking, affinity purification and immunoblotting studies verified that all three subunits of this complex are associated with MLPs ( Supplementary Figs 14 and 15 , and data not shown). Thus, the Bag6 complex binds to multiple MLPs through their hydrophobic domains and has a broader specificity than only binding tail-anchored proteins.
To determine when the Bag6 complex first captures MLPs, we analysed ribosome-nascent chains (RNCs) of membrane proteins. When a transmembrane domain (TMD) emerged from the ribosomal 'tunnel', a direct interaction with SRP54 (the signal-sequence-binding subunit of the SRP) was detected by crosslinking experiments (Fig. 3a-c) . By contrast, the Bag6 complex, even though it has been found to reside on such RNCs and is abundant in the cytosol 4 , did not make direct contact with the substrate (Fig. 3b, c) . When the TMD was still inside the ribosomal tunnel, the RNC was not crosslinked to either BAG6 or SRP54 ( Fig. 3c ), even though both complexes can be recruited to such ribosomes 4, 18 . After puromycin release of each of these RNCs (with the TMD inside versus outside the ribosomal tunnel), BAG6 crosslinking was observed (Fig. 3b, c) . Thus, the Bag6 complex captures substrates concomitant with or after the release of nascent chains from the ribosome; these same hydrophobic domains are bound by the SRP as long as the TMD is exposed as an RNC 19 .
Earlier analysis of tail-anchored and non-tail-anchored membrane proteins had shown that only tail-anchored membrane proteins are efficiently loaded onto TRC40 (also known as ASNA1), the targeting factor for tail-anchored protein insertion into the ER 20 . Indeed, modifying a tailanchored protein either by placing cyan fluorescent protein (CFP) polypeptide sequences after the TMD (a construct denoted b-CFP) ( Fig. 3a ) or by adding an extra TMD (denoted TR-b) reduced the interactions with TRC40 and simultaneously increased the interactions with the Bag6 complex ( Fig. 3d) . Similarly, comparison of the crosslinking partners of PrP and those of the tail-anchored protein Sec61b showed that both of these proteins interact with the Bag6 complex, but only Sec61b is primarily found bound to TRC40 ( Supplementary Fig. 15 ). Given that the loading of tail-anchored proteins onto TRC40 depends on the Bag6 complex 4 , these data suggest that the Bag6 complex is acting as a triage 
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factor: that is, it captures a relatively broad range of membrane proteins after their ribosomal release but transfers only a subset of them (namely, tail-anchored proteins) to TRC40 for post-translational membrane insertion. The remainder seem to be targeted for ubiquitination because of their persistent interaction with BAG6.
To examine this hypothesis, we immunodepleted the Bag6 complex from RRL ( Supplementary Fig. 16 ) and found that the ubiquitination of several MLPs was reduced ( Fig. 4a and Supplementary Fig. 17 ). By contrast, the control protein GFP was not ubiquitinated in RRL but became a substrate when it was attached to either a ubiquitin molecule or any of several hydrophobic ER-targeting domains ( Supplementary Fig. 18 ). Only the hydrophobically modified GFP proteins were BAG6 dependent in their ubiquitination, consistent with their interaction with BAG6 by crosslinking analysis ( Supplementary Fig. 13 ). Conversely, DSSDGPI-PrP, which does not interact with BAG6 ( Fig. 2e ), was ubiquitinated (albeit slowly and less efficiently) in a BAG6-independent manner (Fig. 4a ). Disrupting the TMD of Sec61b with three arginine residues (denoted b(3R)), which disrupts BAG6 interaction 4 , also resulted in less ubiquitination, which was no longer BAG6 dependent (Fig. 4a ). Thus, the Bag6 complex is not required for ubiquitination of all misfolded proteins but is especially important for the efficient ubiquitination of MLPs.
When recombinant BAG6 ( Supplementary Fig. 16 ) was added to translation extracts that had been depleted of the Bag6 complex, the ubiquitination of a model MLP was restored (Fig. 4b) , and the recombinant BAG6 interacted with this MLP in crosslinking assays ( Fig. 4c ).
BAG6 lacking its N-terminal UBL domain (DUBL-BAG6) was inactive in restoring ubiquitination ( Fig. 4b ) despite interacting normally with substrate ( Fig. 4c ). This finding suggested that BAG6 may recruit the ubiquitination machinery to substrates through its UBL domain. To test this, Flag-tagged recombinant BAG6 or DUBL-BAG6 was added to the Fr-RRL translation system lacking the E2 enzyme UBCH5 (Supplementary Fig. 7 ). BAG6-substrate complexes were immunopurified through the Flag tag and incubated with purified E1 ubiquitinactivating enzyme, E2 enzyme, ubiquitin and ATP. Substrate ubiquitination was observed with BAG6 but not DUBL-BAG6, verifying that the UBL domain recruits the ubiquitination machinery to the substrate ( Supplementary Fig. 19 ). Indeed, BAG6 has been observed to interact with E3 ubiquitin ligases through its UBL domain 21, 28 .
In Fig. 4b , c, the data indicated that DUBL-BAG6 should act as a dominant negative and partly stabilize BAG6 substrates, thereby providing a selective tool for in vivo analysis. We therefore overexpressed the Bag6 complex or the DUBL-Bag6 complex (by about twofold) ( Supplementary Fig. 20) in cultured cells and assessed the levels of a co-expressed MLP substrate. A translocation-impaired signal-sequence mutant of PrP (termed N3a-PrP) 5 was stabilized by the DUBL-Bag6 complex but almost unaffected by the wild-type Bag6 complex (Fig. 4d) . Importantly, DSSDGPI-PrP, which does not interact with BAG6 ( Fig. 2e) , was unaffected by either Bag6 complex or DUBL-Bag6 complex overexpression ( Fig. 4d ) and showed higher steady-state levels than N3a-PrP (data not shown). This finding suggests that degradation is occurring by a different quality control pathway, consistent with the failure of DSSDGPI-PrP to be recognized as an MLP (Fig. 2e) .
Wild-type PrP, the translocation of which is slightly inefficient in vivo 2,3,6,8-10 , showed preferential stabilization of a non-glycosylated species when co-overexpressed with DUBL-Bag6 complexes ( Fig. 4e and Supplementary Fig. 21 ). This species was stabilized by proteasome inhibition and had been shown in earlier studies to be a non-translocated PrP precursor 2, 3, 9, 10 . Replacing the slightly inefficient PrP signal sequence with the efficient signal from preprolactin (Prl-PrP) precluded the generation of non-glycosylated PrP with either proteasome inhibition or DUBL-Bag6 complex overexpression (Fig. 4e ). Although the extent of stabilization seems modest, it is comparable to that seen after 2 h proteasome inhibition ( Supplementary Fig. 21 ). Partial knockdown of BAG6 with a short hairpin RNA (shRNA) similarly stabilized a nonglycosylated species of PrP ( Supplementary Fig. 22 ). Thus, MLPs are not only generated in vivo 2,3,6,8-10 , but also require functional BAG6 for maximally efficient degradation.
Our results reveal a pathway for MLP degradation and identify an unexpectedly close link with protein targeting (Fig. 4f ). Ribosomes synthesizing nascent membrane proteins can recruit both the SRP and Bag6 complex on entry of the first hydrophobic segment into the ribosomal tunnel 4, 18 . This is a potential targeting complex for the ER membrane in both the co-translational and post-translational membrane-protein insertion pathways. We now find that such ribosomes are also potential degradation complexes because the first component of this degradation pathway is already poised to act in the event of failed targeting or inappropriate release from the ribosome. BAG6 therefore imposes a degradative fate on membrane proteins that can be avoided only by productive targeting.
Because membrane proteins would never fold in the cytosol, their direct degradation by a specialized pathway may be important to avoid unnecessarily occupying essential cellular folding pathways, particularly under conditions of stress. MLPs are distinguished from nascent cytosolic proteins by relatively long linear hydrophobic stretches, a feature that is important for BAG6 recognition. Indeed, mutagenesis shows that even modest reductions of TMD hydrophobicity sharply curtail BAG6 interaction 4 . This specificity distinguishes BAG6 from more general chaperones such as heat-shock protein 70 (HSP70), the substrate-binding pocket of which seems more suited to the shorter, moderately hydrophobic segments that typify nascent cytosolic proteins. This differential specificity probably explains how MLPs are triaged differently from other constructs (listed at bottom) were assayed for ubiquitination in lysates containing Bag6 complex (control, cont) or lacking Bag6 complex (DBag6). The gels for assessing ubiquitination for the DSSDGPI and b(3R) constructs were exposed about threefold longer than those for PrP and Sec61b. b, Bag6-complex-depleted lysates (DBag6) were replenished with increasing amounts (wedges) of recombinant BAG6 ( Supplementary Fig. 16 Fig. 20) , and PrP was detected by immunoblotting. One sample was treated with the proteasome inhibitor MG132 (MG) for 4 h. A loading control (control) is also shown. e, Effect of the DUBL-Bag6 complex on wild-type PrP and Prl-PrP. Unglycosylated precursor PrP (pre) is preferentially stabilized by either overexpression of the DUBL-Bag6 complex or inhibition of the proteasome. f, The model we propose is that the Bag6 complex captures ribosomally released hydrophobic proteins (red arrows) and triages them between post-translational targeting (for tail-anchored (TA) proteins) and ubiquitination.
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potential substrates of cytosolic quality control 15, 16, [22] [23] [24] [25] [26] [27] [28] . These pathways could intersect or cooperate in as yet undefined ways given that BAG6 and HSP70 have been observed to co-immunoprecipitate 26 .
In addition to this role in degradation, the Bag6 complex also facilitates the loading of tail-anchored proteins onto TRC40 for post-translational insertion into the ER 4 . As expected, tail-anchored proteins were also ubiquitinated by way of BAG6 in the absence of, or saturation of, TRC40 ( Supplementary Fig. 23 ). Thus, substrates of both the cotranslational and post-translational targeting pathways are ubiquitinated in a BAG6-dependent manner when targeting fails. After ubiquitination, BAG6 might chaperone its polyubiquitinated substrates to the proteasome, a function that was recently proposed on the basis of the coimmunoprecipitation of BAG6 with polyubiquitinated proteins 26 . The Bag6 complex is therefore a multi-purpose triage factor for chaperoning especially hydrophobic proteins through the aqueous cytosol. This view conceptually links its roles in tail-anchored protein targeting 4, 17 , in the MLP pathway (in this study), as a chaperone for newly dislocated proteins during ER-associated protein degradation 27, 28 and in the delivery of terminally misfolded proteins to the proteasome 26 .
METHODS SUMMARY
Reagents and standard methods. The plasmids and antibodies used and the assays carried out (in vitro translation assays, sucrose gradient separations, chemical crosslinking analyses, immunoprecipitation assays and immunodepletion assays) were as previously described [2] [3] [4] [5] [6] [7] [8] 14, 20, 29, 30 . Pull-down assays with Co 21 immobilized on chelating sepharose were performed on samples that had been denatured in boiling 1% SDS and then diluted tenfold in 4 uC pull-down buffer: 0.5% Triton X-100, 25 mM HEPES, 100 mM NaCl and 10 mM imidazole. Culture, transfection and immunoblotting analysis of N2a cells (dominant-negative inhibition experiments) and HeLa cells (for shRNA experiments) were carried out as previously described 2,3 . Full-length BAG6 (or DUBL-BAG6, which lacks residues 15-89) tagged at the C terminus with a Flag epitope was overexpressed after transient transfection of HEK-293T cells and then purified with anti-Flag resin under high salt (400 mM potassium acetate) conditions. Modified translation extracts. Fr-RRL contained native ribosomes (isolated from RRL) mixed with a diethylaminoethyl (DEAE) sepharose ion-exchange chromatography elution fraction prepared from ribosome-free RRL ( Supplementary Fig. 7 ). Fr-RRL was adjusted to the following final conditions for translation: 72 mM potassium acetate, 2.5 mM magnesium acetate, 10 mM HEPES, pH 7.4, 2 mM dithiothreitol (DTT), 0.2 mg ml 21 liver transfer RNA, 1 mM ATP, 1 mM GTP, 12 mM creatine phosphate, 40 mg ml 21 creatine kinase, 40 mM each amino acid (except methionine) and 1 mCi ml 21 [ 35 S]methionine. Ubiquitination assays. For full-length proteins, translations containing 10 mM His-tagged ubiquitin were carried out for 1 h at 32 uC. In Fr-RRL, post-translational ubiquitination was initiated by adding E2 enzyme to a final concentration of 250 nM and incubating for 1 h at 32 uC. For RNCs, samples were supplemented with E1 enzyme (85 nM), E2 enzyme (usually 250 nM or 500 nM), cytosol (RRL or Fr-RRL), 10 mM His-ubiquitin, an ATP-regenerating system (1 mM ATP, 10 mM creatine phosphate and 40 mg ml 21 creatine kinase) and 1 mM puromycin. The reaction conditions were 100 mM potassium acetate, 50 mM HEPES, pH 7.4, 5 mM MgCl 2 and 1 mM DTT. Incubations were carried out for 1 h at 32 uC. Onbead ubiquitination of affinity-purified products was carried out under the same conditions, except without the inclusion of puromycin.
METHODS
Plasmids and antibodies. The SP64 vector-based constructs encoding bovine preprolactin, PrP, DSS-PrP (lacking residues 2-22), DSSDGPI-PrP (additionally lacking residues 232-254) and HA-tagged PrP (with the epitope inserted at codon 50) have been characterized previously 3, 5, [29] [30] [31] [32] . Prl-PrP and NPY-PrP encode versions in which the N-terminal signal sequence (residues 1-22) of PrP was replaced 5 with that of either bovine preprolactin or human neuropeptide Y (NPY). N3a-PrP contains a mutated signal sequence (WL was replaced with DD at residues 7 and 8) that is translocation deficient 5 . The lysine-free version of PrP was provided by C. Ott and made by standard mutagenesis methods. Wildtype Sec61b (appended at the C terminus with an epitope recognized by the 3F4 antibody), Sec61b(3R), Sec61b-CFP and CFP-Sec61b have been described previously 4, 20 . Sec61b-TR (referred to as TR-b in the text and figures) contains the TMD of the human transferrin receptor (IAVIVFFLIGFMIGYLGY) at codon 50 in the cytosolic domain of Sec61b 4 . This positions the TMD of TR outside the ribosomal tunnel when the Sec61b TMD is inside the tunnel 4 . RT-b contains an irrelevant hydrophilic sequence (YPKYPIMNPIKKKTITAI) at the same position 4 . GFP, SS/GPI-GFP (containing the N-terminal signal sequence of bovine preprolactin and the C-terminal GPI anchoring sequence of PrP), ManII-GFP (containing the N-terminal type II signal anchor domain of Golgi a-mannosidase II) and SiT-GFP (containing the type II signal anchor domain of sialyl transferase) have been described previously [32] [33] [34] . The plasmid encoding Vpu (a type-I-signalanchored membrane protein from HIV-1) was obtained from J. Bonifacino and J. Magadán 35 . An expression plasmid for bovine rhodopsin has been characterized 29 . For translations of full-length products, the open reading frames were PCR amplified using a forward 59 primer annealing to or encoding an SP6 or T7 promoter, and a reverse primer in the 39 untranslated region at least 100 nucleotides beyond the stop codon. For RNCs, the reverse primer annealed in the coding region and lacked a stop codon. PrP and Vpu RNCs included the entire open reading frame except for the stop codon. The RNCs of b-CFP encoded 46 residues beyond the TMD such that this domain would fully emerge from the ribosome. Similarly, the RNCs of TR-b and RT-b encoded up to and including the TMD of Sec61b such that the TR and RT sequences emerge from the ribosome. Genetic constructs encoding BAG6-Flag and DUBL-BAG6-Flag (lacking residues 15-89 of BAG6)-both encoding human BAG6 containing a C-terminal Flag epitopewere subcloned into a mammalian expression vector by using standard methods. Expression vectors for human TRC35 and UBL4A containing C-terminal Flag tags were obtained from OriGene. Expression vectors for shRNAs directed against human BAG6 were from OriGene. The target sequences were TGACGGCT CTGCTGTGGATGTTCACATCA and CAGCTATGTCATGGTTGGAACCT TCAATC. The irrelevant sequence used as a control was GCACTACCAG AGCTAACTCAGATAGTACT. Antibodies specific for BAG6, TRC40, TRC35, UBL4A and Sec61b have been described previously 4, 36 . Anti-SRP54 (BD Biosciences), anti-ubiquitin (BIOMOL), and 3F4 anti-PrP monoclonal antibodies (Signet) were purchased. In vitro translation. In vitro transcription and translation in RRL was carried out with minor modifications to published procedures 30 . The most notable change was the inclusion in most experiments of 10 mM His-tagged ubiquitin (Boston Biochem) to facilitate the subsequent isolation of ubiquitinated products. Preliminary experiments showed that, at this concentration, endogenous ubiquitin was more than 90% competed out, resulting in few or no untagged ubiquitinated products. Translation times, unless otherwise indicated, were 1 h at 32 uC. Shorter times for tail-anchored proteins (as used in our earlier studies) resulted in very little ubiquitination 4, 20 , presumably because saturation of TRC40 is required before substrates occupy the Bag6 complex 4 . To generate RNCs, the translation times were typically reduced to 30 min to minimize spontaneous release or hydrolysis of the tRNA. Translocation assays into rough microsomes 5 , inhibition by cotransin 29 and inactivation with NEM 37 treatment were carried out as previously described. For direct analysis or downstream immunoprecipitation, translation reactions were stopped, and the proteins were denatured using 1% SDS and heating to 100 uC. For other applications requiring native complexes (for example, crosslinking, affinity purification or downstream assays), samples were placed on ice, and subsequent manipulations were performed at 0-4 uC. Sucrose gradient separation and crosslinking. To generate RNCs, translation reactions (typically 200 ml volume) were chilled on ice and immediately layered onto 2-ml 10-50% sucrose gradients in physiological salt buffer (PSB; 100 mM potassium acetate, 50 mM HEPES, pH 7.4, and 2 mM magnesium acetate). Centrifugation was carried out for 1 h at 55,000 r.p.m. at 4 uC in a TLS-55 rotor (Beckman), after which 200 ml fractions were removed from the top. The peak ribosomal fractions (6 and 7) were pooled and used as the RNCs. These were used immediately or flash frozen in liquid nitrogen for later use in RNC crosslinking or ubiquitination experiments. Chemical crosslinking experiments were essentially carried out as described previously 4, 20 . Chilled translation reactions were layered onto 2-ml 5-25% sucrose gradients in PSB and centrifuged for 5 h at 55,000 r.p.m. at 4 uC in a TLS-55 rotor, after which 200 ml fractions were removed from the top. Crosslinking experiments used 250 mM BMH, except for in experiments to detect SRP interaction, which used 200 mM DSS. Reactions were carried out for 30 min at either 0 uC (BMH) or 25 uC (DSS) and quenched with 25 mM 2-mercaptoethanol (BMH) or 100 mM Tris (DSS). The samples were subsequently denatured and subjected to direct analysis or immunoprecipitation as described below. Photocrosslinking was carried out by following published methods 38 , except that we used the Fr-RRL system for translation and benzophenone-modified lysyl-tRNA (tRNA Probes). The absence of endogenous charged tRNAs and haemoglobin increased photocrosslinker incorporation and photolysis, respectively. Photolysis was carried out for 15 min on ice, and the samples were analysed directly. Modified translation extracts. Fr-RRL was typically prepared from 25 ml RRL (Green Hectares) that had first been treated with haemin and micrococcal nuclease. Its characterization will be described in a future publication, but its preparation is as follows. All procedures were carried out on ice or at 4 uC. The lysate was centrifuged at 100,000 r.p.m. for 40 min in a TLA100.4 rotor (Beckman). The supernatants were pooled, and the tubes rinsed (without disrupting the ribosomal pellet) with an equal volume of column buffer (20 mM Tris, pH 7.5, 20 mM KCl, 0.1 mM EDTA and 10% glycerol), which was added to the supernatant. The pellet was resuspended by dounce homogenization in ribosome wash buffer (RWB; 20 mM HEPES, pH 7.5, 100 mM potassium acetate, 1.5 mM magnesium acetate and 0.1 mM EDTA), layered onto a 1 M sucrose cushion in RWB, and re-isolated by centrifugation at 100,000 r.p.m. for 1 h in a TLA100.4 rotor. The final pellet was resuspended in onetenth of the original lysate volume and defined as 'native ribosomes'. The ribosomefree supernatant from above was applied to a 10 ml DEAE column at a flow rate of ,1 ml min 21 and washed with column buffer until the red haemoglobin was removed (,50 ml). The elution was carried out in a single step with 50 ml column buffer containing 300 mM KCl. The eluate was adjusted slowly with solid ammonium sulphate to 75% saturation (at 4 uC) with constant stirring. After 1 h mixing, the precipitate was recovered by centrifugation at 15,000 r.p.m. in a JA-17 rotor (Beckman). The supernatant was discarded, and the pellet was dissolved in a minimal volume (,8 ml) of dialysis buffer (20 mM HEPES, pH 7.4, 100 mM potassium acetate, 1.5 mM magnesium acetate, 10% glycerol and 1 mM DTT). This solution was dialysed against two changes of dialysis buffer overnight, recovered, adjusted to 10-12 ml (that is, twice the original concentration) and flash frozen in liquid nitrogen. To make a translation-competent Fr-RRL, the native ribosomes and dialysed DEAE eluate were adjusted to 72 mM potassium acetate, 2.5 mM magnesium acetate, 10 mM HEPES, pH 7.4, 2 mM DTT, 0.2 mg ml 21 liver tRNA, 1 mM ATP, 1 mM GTP, 12 mM creatine phosphate, 40 mg ml 21 creatine kinase, 40 mM each amino acid (except for methionine) and 1 mCi ml 21 [ 35 S]methionine. The concentration of ribosomes and lysate was the same as that for RRL. Immunodepletions of RRL were carried out as described previously 4 . Ubiquitination assays. The human E1 enzyme and all mammalian E2 enzymes were obtained from Boston Biochem. For full-length proteins, translations containing 10 mM His-ubiquitin were carried out for 1 h at 32 uC. In Fr-RRL, post-translational ubiquitination was initiated by adding E2 enzyme to a final concentration of 250 nM and further incubating for 1 h. For RNCs, samples were supplemented (as indicated in the figures) with E1 enzyme (85 nM), E2 enzyme (usually 250 or 500 nM), cytosol (RRL or Fr-RRL, at the same concentration as in the translations), 10 mM His-ubiquitin, an ATP-regenerating system (1 mM ATP, 10 mM creatine phosphate and 40 mg ml 21 creatine kinase) and 1 mM puromycin. Reaction conditions were 100 mM potassium acetate, 50 mM HEPES, pH 7.4, 5 mM MgCl 2 and 1 mM DTT. Incubation was for 1 h at 32 uC. On-bead ubiquitination of affinity-purified products was carried out under the same conditions, except for without puromycin. To prepare the affinity-purified substrate, translation reactions in Fr-RRL were chilled on ice, diluted to 1 ml in PSB and incubated with immobilized antibodies against the HA epitope (for PrP-HA and Vpu-HA) or Sec61b. In Supplementary Fig. 9 , the translation reactions were supplemented with Flag-tagged BAG6 or DUBL-BAG6 (each added to twofold excess above endogenous BAG6 levels), and anti-Flag beads (Sigma) were used for the pulldown. After 1 h, the resin was washed five times in PSB, and the residual buffer was carefully removed before adding the ubiquitination components as above. The reaction was incubated with constant low-level shaking (in a Thermomixer, Eppendorf) at 32 uC for 1 h. SDS (1%) was added directly to the reactions, which were analysed directly and after ubiquitin pull-downs. Cell culture studies. Culture, transfection and immunoblotting analysis of N2a cells (dominant-negative inhibition experiments) and HeLa cells (for shRNA experiments) were carried out as described previously 2, 3 . Cells were seeded in 24-well dishes the day before transfection. For the dominant-negative experiments, the plasmids were mixed in the ratios indicated in Supplementary Fig. 20 and transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. At 24 h after transfection, the cells were harvested in 1% SDS;
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the DNA was sheared by vortexing and boiling; and the total sample was analysed by SDS-PAGE and immunoblotting. For shRNA experiments, each well received a mixture of 550 ng shRNA plasmid, 200 ng PrP expression plasmid and 50 ng CFP expression plasmid. Transfection was effected with Lipofectamine 2000. Examination of CFP fluorescence verified at least 50% transfection efficiency. The cells were cultured for ,100 h before collection and analysis by immunoblotting. BAG6 purification. Full-length BAG6 or DUBL-BAG6 tagged at the C terminus with a Flag epitope was overexpressed by transient transfection of HEK-293T cells.
TransIT reagent (Mirus) was used. After 3 days of expression, the cells were collected in 50 mM HEPES, pH 7.4, 150 mM potassium acetate, 5 mM magnesium acetate and 1% deoxy Big CHAP. The soluble extract was incubated with immobilized anti-Flag antibodies (Sigma) with constant mixing, and the resin was washed four times with high salt lysis buffer containing 400 mM potassium acetate and then twice with detergent-free lysis buffer containing 230 mM potassium acetate. Elution was carried out with 1 mg ml 21 competing peptide at room temperature. The final protein was checked by using colloidal Coomassie blue ( Supplementary Fig. 16 ), and its concentration relative to that in RRL was determined by immunoblotting of serial dilutions. Blotting also confirmed the lack of TRC35 and UBL4A in BAG6 prepared by this method. Miscellaneous biochemistry. Immunoprecipitation assays were carried out as described previously 5, 36 . Pull-down assays with Co 21 immobilized on chelating sepharose were performed on samples denatured in boiling 1% SDS and then diluted tenfold in cold (4 uC)0.5% Triton X-100, 25 mM HEPES, 100 mM NaCl and 10 mM imidazole. The complete denaturation step is essential for samples containing RRL because the haemoglobin is a strong Co 21 -binding protein in its native state. Typically, 10 ml packed resin was used per sample, and after incubation for 1-2 h at 4 uC, the resin was washed three times in the above buffer and eluted in SDS-PAGE sample buffer containing 20 mM EDTA. SDS-PAGE was carried out using 8.5% or 12% tricine gels. Figures were prepared using the programs Photoshop and Illustrator (Adobe).
